Table 7.
Diagnostic threshold | NMB* CE threshold £30 000 per QALY |
Probability cost-effective CE threshold £20 000 per QALY (%) |
Probability cost-effective CE threshold WTP=£30 000 per QALY (%) |
No treatment | £0 | 54.1 | 21.0 |
NICE 2015 | £239 902 | 43.3 | 51.5 |
WHO 2013 | £186 675 | 2.7 | 27.6 |
*NMB is measured relative to a baseline of no treatment
CE, cost-effectiveness; HAPO, Hyperglycaemia and Adverse Pregnancy Outcomes; NICE, National Institute for Health and Care Excellence; NMB, net monetary benefit; QALY, quality-adjusted life year; WTP, willingness to pay.